Excelia business school, University in La Rochelle, France

Seoul, Dec 14 British-Swedish pharmaceutical giant AstraZeneca on Tuesday said that Samsung Biologics, the biotech arm of Samsung Group, will manufacture its antibody combination against Covid-19.Under an agreement valued at approximately $380 million, Samsung Biologics will manufacture Evusheld AstraZeneca's combination of two long-acting antibodies in development for the potential treatment of Covid-19 at its plant in Songdo, Incheon, 40 km west of Seoul, Yonhap news agency reported.The deal represents a hike from a long-term supply agreement valued at $331 million signed between the two firms in September.Evusheld is an injectable monoclonal antibody cocktail and has been approved for pre-exposure prophylaxis, or PrEP, against Covid-19 among individuals aged 12 and older and who are not currently infected with the SARS-CoV-2 virus and who have not recently been exposed to an individual infected with SARS-CoV-2.It is the first antibody treatment against Covid-19 that has won an Emergency Use Authorization from the US Food and Drug Administration (FDA). It has also won approval from drug authorities in other countries, including France and Italy.The cocktail is made up of Tixagevimab and cilgavimab long-acting monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2. It is designed to block the virus' attachment and entry into human cells. Tixagevimab and cilgavimab bind to different, non-overlapping sites on the spike protein of the virus, the FDA said.AstraZeneca has also said it is testing Evusheld against the new Omicron variant, that has so far spread to more than 60 countries.The deal also includes Samsung Bioglogics manufacturing AstraZeneca's oncology drug Imfinzi at its plant starting next year, the report said.Imfinzi has won approval in many countries, including South Korea, for the treatment of lung cancer. The drug is currently under study for the treatment of other cancers.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Excelia Business SchoolFOLLOW

Excelia business school, Latest News

In France, citizens will be given the right to choose their last name in a very simple way. A ... ...

Lokmat News Network Aurangabad, Dec 20: A farmer’s son Dr Dhanaji Jawale has developed a new method for hydrogen ... ...

A study has found that a molecular switch influences addiction behaviour and determines how strong the response to addictive drugs is. ...

Paris, Dec 18 French Prime Minister Jean Castex announced a series of new measures to curb the spread ... ...

Paris, Dec 18 French Prime Minister Jean Castex has announced a series of measures to curb the spread ... ...

Prime Minister Narendra Modi met French Defence Minister Florence Parly here and discussed regional security and co-operation in Indo-Pacific. ...

Paris, Dec 15 Paris-based taxi company G7, which reportedly operates one of the largest Tesla taxi fleets in ... ...

Seoul, Dec 14 British-Swedish pharmaceutical giant AstraZeneca on Tuesday said that Samsung Biologics, the biotech arm of Samsung ... ...